Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 11; p. 1021
Main Author Shah, Adnan
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 19.05.2020
Subjects
COVID-19
cytokines
Immunology
NLRP3 inflammasome
SARS-CoV
viroporins
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology
Reviewed by: Takeshi Ichinohe, University of Tokyo, Japan
Edited by: Yasuko Tsunetsugu Yokota, Tokyo University of Technology, Japan
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2020.01021